Related Experiment Video

Updated: Apr 30, 2026

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens
13:47

Opsono-Adherence Assay to Evaluate Functional Antibodies in Vaccine Development Against Bacillus anthracis and Other Encapsulated Pathogens

Published on: May 19, 2020

3.0K

Pediatric anthrax clinical management

John S Bradley, Georgina Peacock, Steven E Krug

    Pediatrics
    |April 30, 2014
    PubMed

    Insights

    This guidance provides clinical recommendations for treating Bacillus anthracis infections in children following a potential bioterrorism event. It addresses prophylaxis and treatment tailored to pediatric patients up to age 21.

    Area of Science:

    • Infectious Diseases
    • Public Health
    • Pediatrics

    Background:

    • Anthrax is a zoonotic disease caused by Bacillus anthracis.
    • Bacillus anthracis can be a biological weapon, leading to rapid, fatal systemic disease if untreated.
    • Children have unique physiological characteristics that require specific clinical guidance.

    Purpose of the Study:

    • To provide clinical guidance for the prophylaxis and treatment of anthrax in children.
    • To address the unique needs of pediatric patients (up to age 21) in the event of a deliberate Bacillus anthracis release.
    • To offer recommendations that differ from adult guidelines when necessary.

    Main Methods:

    • Review of existing clinical data and expert consensus on anthrax treatment.
    • Adaptation of adult treatment protocols for pediatric populations.
    • Consideration of age-specific dosing and administration routes.

    Main Results:

    • Specific recommendations for antibiotic prophylaxis and treatment regimens for pediatric anthrax.
    • Guidance on managing different routes of infection in children.
    • Considerations for monitoring and supportive care in pediatric patients.

    Conclusions:

    • Standardized clinical guidance is crucial for managing pediatric anthrax post-release.
    • Tailored pediatric protocols are essential for effective prophylaxis and treatment.
    • Preparedness for bioterrorism events involving Bacillus anthracis must include specific pediatric considerations.

    Keywords:
    anthraxanthrax vaccinebiological weaponbioterrorismchildrenpediatricsprophylaxis

    More Related Videos

    Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA12:18

    Subcutaneous Infection of Methicillin Resistant Staphylococcus Aureus MRSA

    Published on: February 9, 2011

    22.2K

    Related Concept Videos

    Pneumonia IV: Management01:28

    Pneumonia IV: Management

    The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
    Bacterial Pneumonia Treatment
    For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
    1.2K
    Pneumonia V: Nursing management and Prevention01:30

    Pneumonia V: Nursing management and Prevention

    Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
    The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
    Enhance airway patency
    Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
    4.2K
    Pharmaceutical Poisoning: Treatment Strategies01:26

    Pharmaceutical Poisoning: Treatment Strategies

    Treatment strategies for poisoning are a critical aspect of emergency medicine, focusing on preventing the absorption of toxins and enhancing their elimination. When a poisoning incident occurs, the first response is to halt exposure and decontaminate the patient, particularly through gastrointestinal (GI) methods if the poison was ingested.Gastrointestinal Decontamination Techniques:Activated charcoal is the cornerstone of GI decontamination. It works through adsorption, binding the toxin to...
    279
    Pulmonary Tuberculosis V01:28

    Pulmonary Tuberculosis V

    Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
    Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
    1.0K
    Acute Pyelonephritis II: Diagnostic Studies and Management01:28

    Acute Pyelonephritis II: Diagnostic Studies and Management

    Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
    842
    Clinical Significance of Antibiotic Resistance01:25

    Clinical Significance of Antibiotic Resistance

    Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within...
    90